What? An update on the World Health Organization's and its partners' activities in the field of promoting access, quality and rational use of essential medicines for HIV & AIDS. Particular emphasis will be on issues of selection, safety, quality and pricing. There will be an opportunity for questions and an open discussion on medicine-related topics.
Participants:
World Health Organization, Clinton Foundation HIV/AIDS Initiative, The Global Fund for AIDS, TB and Malaria, Supply Chain Management System (SCMS), UNICEF, and UNITAID
Selection and Safety
Health Systems Strengthening, Primary Health Care & medicines as a human right
Hans Hogerzeil - Director, Essential Medicines and Pharmaceutical Policies, WHO
Treating all children with HIV - should we treat infants with protease inhibitors?
Siobhan Crowley - Medical Officer, Antiretroviral treatment and HIV Care, WHO
Panel discussion also with:
Helene Moller - Medicine Access and Rational Use, WHO
James Fitzgerald - Pan-American Health Organization, WHO
Atieno Ojoo - Supply Division, UNICEF
Quality and Pricing
Supporting efforts to increase access to quality medicines for children
Atieno Ojoo - Supply Division, UNICEF
Ensuring quality of medicines procured with global funds
Joelle Daviaud - Procurement Team, The Global Fund for AIDS, TB and Malaria
Investing in the quality of medicines
Jorge Berumudez - Executive Secretary, UNITAID
Price trends of HIV and AIDS medicines - finding and using data
Joseph Perriens - Coordinator, Systems Strengthening and HIV AIDS, WHO
Panel discussion also with:
David Jamieson - Deputy Director for Country programs and Partnerships at the PEPFAR-fund Supply Chain Management System (SCMS) Dai Ellis - Director Drug Access Team, Clinton Foundation HIV/AIDS Initiative
